<?xml version='1.0' encoding='UTF-8'?>
<DOC><DOCNO>WSJ910226-0027</DOCNO><DOCID>910226-0027.</DOCID><HL>   OTC Focus:   Stock Prices Continue to Move Higher   But Some Biotechnology Issues Decline   ----   By Anne Newman   Staff Reporter of The Wall Street Journal</HL><DATE>02/26/91</DATE><SO>WALL STREET JOURNAL (J), PAGE C6</SO><IN>OTC GENERAL MARKET COMMENTARY (OTC)STOCK MARKET, OFFERINGS (STK)STOCK INDEXES (NDX)U.S. STOCK MARKET STATISTICS (STT)</IN><LP>   NEW YORK -- Highflying biotechnology shares faded but theover-the-counter stock market continued its upward march,again upstaging larger stocks traded on the major exchanges.   The Nasdaq Composite Index rose 2.14 to 451.09, a 0.5%gain, compared with a 0.4% rise in the New York StockExchange Composite Index and a 0.05% decline in the Dow JonesIndustrial Average. OTC volume eased to 149.3 million sharesfrom more than 177 million Friday. Advancing stocks racedahead of decliners, 1,101 to 773, as 123 stocks rose to newhighs and only 14 dropped to new lows.</LP><TEXT>   Amgen, the bellwether biotechnology issue, slipped 2 7/8to 98 7/8 and led a few other biotechnology stocks lower,including Centocor, which eased 1 1/4 to 61 3/4. Amgencompetitors, however, continued to advance.   Genetics Institute rose 1 to 60 1/2 and Immunex jumped 31/2 to 49.   Amgen had burst through the $100-a-share mark Friday to101 3/4, leaping 13 points in two days after Thursday'sapproval by the Food and Drug Administration of the ThousandOaks, Calif., company's new product for cancer treatment.&quot;From a trading standpoint, it looked like a feeding frenzy(in biotechnology stocks) getting out of control,&quot; said PeterDa Puzzo, co-head of world-wide equities for Shearson LehmanBrothers of New York. Yesterday PaineWebber analyst LindaMiller lowered her rating on Amgen to &quot;neutral&quot; from &quot;buy,&quot;reflecting the stock's sharp run-up.   Other OTC leaders showed narrow gains or losses. Microsoftadded 3/4 to 103, Intel gained 1/4 to 50 and Sun Microsystemsadvanced 3/4 to 33. Apple Computer, however, fell 1 3/4 to58.   Investors were quick to sell the shares of technologycompanies that hinted of disappointments. Borland fell 2 to47 3/4 after trading as low as 43 3/8. Cowen andamp; Co. analystMary Meeker told Dow Jones Professional Investor Report thatshe cautioned investors that Borland might not release a newspreadsheet software program for Microsoft's Windows 3.0operating platform as early as expected. Ms. Meeker, however,maintains her &quot;buy&quot; rating on the stock.   Alan Henricks, chief financial officer of the ScottsValley, Calif., software maker, declined to comment.   Investors continued to reward companies with robustearnings and also shopped among the stocks of prospectiveacquisition targets.   Pool Energy Services jumped 1 1/4 to 10 7/8. The Houstonoil and gas service company reported fourth-quarter netincome of 13 cents a share, compared with a loss of ninecents a share a year earlier. Revenue rose to $61.4 millionfrom $52.7 million.   Novell added 1 1/4 to 48 1/4. After the market closed, theProvo, Utah, maker of computer network systems reported thatnet income for its first quarter, ended Jan. 26, rose to 42cents a share from 22 cents a year earlier. The latestquarter included a gain of $8 million realized from the saleof Novell's equity in its Japanese subsidiary. Analysts hadbeen expecting the company to report about 39 cents a share,according to First Call, a unit of Thomson FinancialNetworks.   Employers Casualty gained 3/4 to 3 7/8. The Dallas insurerreported that fourth-quarter net income jumped to 88 cents ashare from 39 cents a year earlier. Losses for the yearwidened to $8.88 a share from a loss of $6.55 a share.   Prospective acquisitions influenced the shares of Wavetek,which rose 1/2 to 2 3/4, and Florida Employers Insurance,which fell 1/2 to 9 1/4.   Wavetek, a San Diego testing concern, said it agreed to beacquired by Torrey Investments for $3.15 a share in cash.   Florida Employers Insurance said it entered into a newletter of intent extending until April 15 a previouslyannounced plan for American Employers Group to buy FloridaEmployers for $16 a share.   Investors pummeled the shares of Healthco Internationalafter the Boston company's plan to be acquired fell through.Healthco, a distributor of dental supplies and equipment,said that it won't be able to satisfy the conditions of aproposed $19.25-a-share acquisition by Hicks Muse andamp; Co.because of an unspecified fourth-quarter loss. Healthco alsosaid that it may report a $5 million loss for the year,citing a &quot;significant&quot; decline in gross profit margins.   Weak earnings toppled other shares.   Lawson Products tumbled 3 to 31 3/4 after the Des Plaines,Ill., maker of fasteners and other parts reported thatfourth-quarter net income fell to 38 cents a share from 45cents. Sales edged up to $45.6 million from $45.1 million.   Markel skidded 1 to 15 after the Glenn Allen, Va.,insurance broker reported fourth-quarter net income fromcontinuing operations fell to 16 cents a share from 58 centsa year earlier.   Elsewhere, ShowBiz Pizza Time slipped 2 to 33. The Irving,Texas, family restaurant concern declared a 3-for-2 stocksplit, payable March 26 to stock of record March 5. ShowBizalso reported that fourth-quarter net income rose to 25 centsa share from seven cents a year earlier, and attributed theimprovement to debt repayments.</TEXT></DOC>